Deerfield Management Company
Latest statistics and disclosures from Deerfield Management Company's latest quarterly 13F-HR filing:
- Top 5 stock holdings are NUVL, CNC, MRUS, VTRS, UTHR, and represent 39.43% of Deerfield Management Company's stock portfolio.
- Added to shares of these 10 stocks: CNC (+$209M), IONS (+$130M), BMY (+$105M), COGT (+$92M), Ionis Pharmaceuticals (+$83M), INSP (+$67M), Neogenomics (+$63M), BCRX (+$57M), Bridgebio Oncology Therapeut (+$57M), Tandem Diabetes Care (+$52M).
- Started 49 new stock positions in CDNA, Ionis Pharmaceuticals, STAA, BSX, AVNS, MNPR, ISRG, PBH, ACHC, ELUT.
- Reduced shares in these 10 stocks: OSCR (-$250M), Integra Lifesciences Hldgs C (-$173M), Alnylam Pharmaceuticals Inc Note 1.000 9/1 (-$143M), INDV (-$86M), UTHR (-$48M), IDYA (-$48M), BAX (-$43M), ALNY (-$35M), INSM (-$33M), MRUS (-$32M).
- Sold out of its positions in Alnylam Pharmaceuticals Inc Note 1.000 9/1, AMED, AMPH, CRL, DCTH, Hillevax, Integra Lifesciences Hldgs C, IQV, LQDA, MEDP. MREO, NPCE, OSCR, PACS, LUNG, RXST, SLP, UHS, PCVX, Xeris Biopharma Holdings, NVCR.
- Deerfield Management Company was a net buyer of stock by $276M.
- Deerfield Management Company has $6.6B in assets under management (AUM), dropping by 18.89%.
- Central Index Key (CIK): 0001009258
Tip: Access up to 7 years of quarterly data
Positions held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data
Download as csvPortfolio Holdings for Deerfield Management Company
Deerfield Management Company holds 152 positions in its portfolio as reported in the September 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Nuvalent Inc-a (NUVL) | 23.8 | $1.6B | 18M | 86.48 |
|
|
| Centene Corporation (CNC) | 4.9 | $323M | +183% | 9.0M | 35.68 |
|
| Merus N V (MRUS) | 4.4 | $287M | -9% | 3.0M | 94.15 |
|
| Viatris (VTRS) | 3.6 | $239M | 24M | 9.90 |
|
|
| United Therapeutics Corporation (UTHR) | 2.7 | $179M | -21% | 426k | 419.21 |
|
| Revolution Medicines (RVMD) | 2.6 | $171M | +7% | 3.7M | 46.70 |
|
| Indivior Ord (INDV) | 2.6 | $169M | -33% | 7.0M | 24.11 |
|
| Mirum Pharmaceuticals Note 4.000% 5/0 (Principal) | 2.6 | $168M | 70M | 2.40 |
|
|
| Neurocrine Biosciences (NBIX) | 2.5 | $166M | 1.2M | 140.38 |
|
|
| Cogent Biosciences (COGT) | 2.0 | $130M | +242% | 9.1M | 14.36 |
|
| Ionis Pharmaceuticals (IONS) | 2.0 | $130M | NEW | 2.0M | 65.42 |
|
| Newamsterdam Pharma Company Ordinary Shares (NAMS) | 1.9 | $121M | -16% | 4.3M | 28.44 |
|
| Vera Therapeutics Cl A (VERA) | 1.6 | $106M | +8% | 3.6M | 29.06 |
|
| Bristol Myers Squibb (BMY) | 1.6 | $105M | NEW | 2.3M | 45.10 |
|
| Adapthealth Corp Common Stock (AHCO) | 1.6 | $103M | +15% | 12M | 8.95 |
|
| Larimar Therapeutics (LRMR) | 1.5 | $99M | +44% | 31M | 3.23 |
|
| Brookdale Senior Living (BKD) | 1.5 | $99M | -24% | 12M | 8.47 |
|
| Catalyst Pharmaceutical Partners (CPRX) | 1.5 | $98M | +72% | 5.0M | 19.70 |
|
| Legend Biotech Corp Sponsored Ads (LEGN) | 1.5 | $97M | 3.0M | 32.61 |
|
|
| BioCryst Pharmaceuticals (BCRX) | 1.4 | $92M | +159% | 12M | 7.59 |
|
| Tandem Diabetes Care Note 1.500% 3/1 (Principal) | 1.3 | $87M | +150% | 100M | 0.87 |
|
| Merck & Co (MRK) | 1.3 | $86M | +20% | 1.0M | 83.93 |
|
| Pfizer (PFE) | 1.3 | $84M | -23% | 3.3M | 25.48 |
|
| Ionis Pharmaceuticals Note 1.750% 6/1 (Principal) | 1.3 | $83M | NEW | 60M | 1.38 |
|
| Certara Ord (CERT) | 1.3 | $82M | +71% | 6.7M | 12.22 |
|
| Inspire Med Sys (INSP) | 1.2 | $78M | +648% | 1.0M | 74.20 |
|
| Silverback Therapeutics (SPRY) | 1.2 | $75M | -22% | 7.5M | 10.05 |
|
| Insmed Com Par $.01 (INSM) | 1.0 | $68M | -32% | 471k | 144.01 |
|
| Bio Rad Labs Cl A (BIO) | 1.0 | $63M | 226k | 280.39 |
|
|
| Neogenomics Note 0.250% 1/1 (Principal) | 1.0 | $63M | NEW | 73M | 0.87 |
|
| Pharvaris N V (PHVS) | 0.9 | $61M | +21% | 2.4M | 24.95 |
|
| Disc Medicine (IRON) | 0.9 | $61M | 919k | 66.08 |
|
|
| Ideaya Biosciences (IDYA) | 0.9 | $59M | -45% | 2.2M | 27.21 |
|
| Bridgebio Oncology Therapeut | 0.9 | $57M | NEW | 4.9M | 11.58 |
|
| Envista Hldgs Corp (NVST) | 0.7 | $47M | +3% | 2.3M | 20.37 |
|
| Praxis Precision Medicines I Com New (PRAX) | 0.7 | $45M | +22% | 841k | 53.00 |
|
| Cormedix Inc cormedix (CRMD) | 0.6 | $39M | NEW | 3.3M | 11.63 |
|
| Enhabit Ord (EHAB) | 0.6 | $38M | 4.7M | 8.01 |
|
|
| Embecta Corp Common Stock (EMBC) | 0.6 | $37M | -4% | 2.6M | 14.11 |
|
| Livanova Note 2.500% 3/1 (Principal) | 0.6 | $37M | +37% | 34M | 1.08 |
|
| Celcuity (CELC) | 0.6 | $36M | NEW | 734k | 49.40 |
|
| CONMED Corporation (CNMD) | 0.5 | $36M | +8% | 760k | 47.03 |
|
| Zenas Biopharma (ZBIO) | 0.5 | $35M | 1.6M | 22.20 |
|
|
| Neogenomics Com New (NEO) | 0.5 | $34M | +107% | 4.4M | 7.72 |
|
| Arrowhead Pharmaceuticals (ARWR) | 0.5 | $34M | NEW | 993k | 34.49 |
|
| Day One Biopharmaceuticals I (DAWN) | 0.5 | $33M | +26% | 4.7M | 7.05 |
|
| Kymera Therapeutics (KYMR) | 0.5 | $32M | -12% | 572k | 56.60 |
|
| Caredx (CDNA) | 0.5 | $32M | NEW | 2.2M | 14.54 |
|
| Alnylam Pharmaceuticals (ALNY) | 0.5 | $31M | -53% | 68k | 456.00 |
|
| Acadia Healthcare (ACHC) | 0.4 | $29M | NEW | 1.2M | 24.76 |
|
| Sionna Therapeutics (SION) | 0.4 | $29M | 971k | 29.41 |
|
|
| Savara (SVRA) | 0.4 | $28M | 8.0M | 3.57 |
|
|
| Immunocore Hldgs Note 2.500% 2/0 (Principal) | 0.4 | $27M | 30M | 0.90 |
|
|
| Lantheus Hldgs Note 2.625%12/1 (Principal) | 0.4 | $27M | 25M | 1.05 |
|
|
| Phreesia (PHR) | 0.4 | $26M | +10% | 1.1M | 23.52 |
|
| Moderna Put Option (MRNA) | 0.4 | $26M | 1.0M | 25.83 |
|
|
| Veracyte (VCYT) | 0.4 | $25M | +16% | 726k | 34.33 |
|
| Ventas (VTR) | 0.4 | $25M | 354k | 69.99 |
|
|
| Beta Bionics (BBNX) | 0.4 | $23M | 1.2M | 19.87 |
|
|
| Xenon Pharmaceuticals (XENE) | 0.3 | $22M | 542k | 40.15 |
|
|
| Taysha Gene Therapies Com Shs (TSHA) | 0.3 | $18M | 5.4M | 3.27 |
|
|
| Cullinan Oncology (CGEM) | 0.3 | $17M | -24% | 2.9M | 5.93 |
|
| Foghorn Therapeutics (FHTX) | 0.2 | $16M | 3.3M | 4.89 |
|
|
| Monopar Therapeutics Com New (MNPR) | 0.2 | $13M | NEW | 160k | 81.67 |
|
| Edgewise Therapeutics (EWTX) | 0.2 | $12M | -62% | 766k | 16.22 |
|
| Omada Health (OMDA) | 0.2 | $12M | 553k | 22.11 |
|
|
| Oncology Institu (TOI) | 0.2 | $12M | 3.4M | 3.49 |
|
|
| Integra Lifesciences Hldgs C Com New (IART) | 0.2 | $11M | 795k | 14.33 |
|
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.2 | $11M | 373k | 28.00 |
|
|
| Spyre Therapeutics Com New (SYRE) | 0.2 | $10M | 614k | 16.76 |
|
|
| Docgo (DCGO) | 0.1 | $6.3M | -6% | 4.6M | 1.36 |
|
| Shoulder Innovations Common Stock | 0.1 | $6.1M | NEW | 483k | 12.55 |
|
| Jade Biosciences Com New (JBIO) | 0.1 | $4.6M | 531k | 8.63 |
|
|
| Align Technology (ALGN) | 0.1 | $4.1M | +1585% | 33k | 125.22 |
|
| Prestige Brands Holdings (PBH) | 0.1 | $4.0M | NEW | 65k | 62.40 |
|
| Calcimedica Com New (CALC) | 0.1 | $4.0M | 1.3M | 3.08 |
|
|
| UFP Technologies (UFPT) | 0.1 | $3.7M | +1130% | 19k | 199.60 |
|
| Orthopediatrics Corp. (KIDS) | 0.1 | $3.6M | +1153% | 194k | 18.53 |
|
| Varex Imaging (VREX) | 0.1 | $3.5M | NEW | 285k | 12.40 |
|
| Merit Medical Systems (MMSI) | 0.1 | $3.5M | NEW | 42k | 83.23 |
|
| Haemonetics Corporation (HAE) | 0.1 | $3.4M | +1857% | 69k | 48.74 |
|
| Heartflow Inc/Sh | 0.1 | $3.4M | NEW | 100k | 33.66 |
|
| Kenvue (KVUE) | 0.0 | $3.1M | NEW | 194k | 16.23 |
|
| Alector (ALEC) | 0.0 | $3.1M | 1.1M | 2.96 |
|
|
| AtriCure (ATRC) | 0.0 | $3.1M | +686% | 88k | 35.25 |
|
| Boston Scientific Corporation (BSX) | 0.0 | $3.1M | NEW | 31k | 97.63 |
|
| 10x Genomics Cl A Com (TXG) | 0.0 | $3.1M | +2211% | 261k | 11.69 |
|
| RadNet (RDNT) | 0.0 | $3.0M | +2550% | 40k | 76.21 |
|
| Irhythm Technologies (IRTC) | 0.0 | $3.0M | NEW | 17k | 171.99 |
|
| Cooper Cos (COO) | 0.0 | $3.0M | +581% | 43k | 68.56 |
|
| PerkinElmer (RVTY) | 0.0 | $2.9M | NEW | 34k | 87.65 |
|
| Biolife Solutions Com New (BLFS) | 0.0 | $2.8M | +713% | 111k | 25.51 |
|
| LeMaitre Vascular (LMAT) | 0.0 | $2.6M | +618% | 30k | 87.51 |
|
| Staar Surgical Com Par $0.01 (STAA) | 0.0 | $2.6M | NEW | 97k | 26.87 |
|
| Trupanion (TRUP) | 0.0 | $2.5M | NEW | 57k | 43.28 |
|
| DaVita (DVA) | 0.0 | $2.5M | +783% | 19k | 132.87 |
|
| Intuitive Surgical Com New (ISRG) | 0.0 | $2.4M | NEW | 5.4k | 447.23 |
|
| Waters Corporation (WAT) | 0.0 | $2.4M | NEW | 7.9k | 299.81 |
|
| CorVel Corporation (CRVL) | 0.0 | $2.3M | +1416% | 30k | 77.42 |
|
| Colfax Corp (ENOV) | 0.0 | $2.1M | +574% | 69k | 30.34 |
|
| Chemed Corp Com Stk (CHE) | 0.0 | $2.1M | NEW | 4.7k | 447.74 |
|
| Alignment Healthcare (ALHC) | 0.0 | $1.8M | -69% | 103k | 17.45 |
|
| Annexon (ANNX) | 0.0 | $1.8M | 584k | 3.05 |
|
|
| National HealthCare Corporation (NHC) | 0.0 | $1.8M | +398% | 15k | 121.51 |
|
| Repligen Corporation (RGEN) | 0.0 | $1.7M | +692% | 13k | 133.67 |
|
| Teleflex Incorporated (TFX) | 0.0 | $1.7M | +651% | 14k | 122.36 |
|
| Ge Healthcare Technologies I Common Stock (GEHC) | 0.0 | $1.6M | NEW | 22k | 75.10 |
|
| Penumbra (PEN) | 0.0 | $1.6M | NEW | 6.4k | 253.32 |
|
| Newamsterdam Pharma Company *w Exp 99/99/999 (NAMSW) | 0.0 | $1.6M | 93k | 17.11 |
|
|
| Dex (DXCM) | 0.0 | $1.5M | NEW | 22k | 67.29 |
|
| Transmedics Group (TMDX) | 0.0 | $1.4M | NEW | 13k | 112.20 |
|
| Halyard Health (AVNS) | 0.0 | $1.4M | NEW | 123k | 11.56 |
|
| Insulet Corporation (PODD) | 0.0 | $1.4M | NEW | 4.5k | 308.73 |
|
| Biomx Com New (PHGE) | 0.0 | $1.3M | 2.5M | 0.53 |
|
|
| Integer Hldgs (ITGR) | 0.0 | $1.3M | NEW | 13k | 103.33 |
|
| Danaher Corporation (DHR) | 0.0 | $1.3M | +3722% | 6.4k | 198.26 |
|
| Zoetis Cl A (ZTS) | 0.0 | $1.3M | +552% | 8.6k | 146.32 |
|
| Bellring Brands Common Stock (BRBR) | 0.0 | $1.2M | NEW | 34k | 36.35 |
|
| Elutia Cl A Com (ELUT) | 0.0 | $1.2M | NEW | 1.4M | 0.89 |
|
| Brooks Automation (AZTA) | 0.0 | $1.2M | NEW | 41k | 28.72 |
|
| Bio-techne Corporation (TECH) | 0.0 | $1.2M | NEW | 21k | 55.63 |
|
| Xeris Pharmaceuticals (XERS) | 0.0 | $984k | +435% | 121k | 8.14 |
|
| Baxter International (BAX) | 0.0 | $973k | -97% | 43k | 22.77 |
|
| Molina Healthcare (MOH) | 0.0 | $966k | NEW | 5.0k | 191.36 |
|
| Alphatec Hldgs Com New (ATEC) | 0.0 | $949k | +282% | 65k | 14.54 |
|
| Adaptive Biotechnologies Cor (ADPT) | 0.0 | $903k | NEW | 60k | 14.96 |
|
| Stryker Corporation (SYK) | 0.0 | $735k | NEW | 2.0k | 369.67 |
|
| MiMedx (MDXG) | 0.0 | $732k | +166% | 105k | 6.98 |
|
| Twist Bioscience Corp (TWST) | 0.0 | $671k | 24k | 28.14 |
|
|
| Healthequity (HQY) | 0.0 | $669k | NEW | 7.1k | 94.77 |
|
| Steris Shs Usd (STE) | 0.0 | $638k | NEW | 2.6k | 247.44 |
|
| Globus Med Cl A (GMED) | 0.0 | $636k | NEW | 11k | 57.27 |
|
| Edwards Lifesciences (EW) | 0.0 | $494k | NEW | 6.3k | 77.77 |
|
| Thermo Fisher Scientific (TMO) | 0.0 | $458k | +3% | 944.00 | 485.02 |
|
| Sotera Health (SHC) | 0.0 | $399k | -43% | 25k | 15.73 |
|
| Dentsply Sirona (XRAY) | 0.0 | $383k | NEW | 30k | 12.69 |
|
| Labcorp Holdings Com Shs (LH) | 0.0 | $303k | NEW | 1.1k | 287.06 |
|
| Service Corporation International (SCI) | 0.0 | $303k | NEW | 3.6k | 83.22 |
|
| Henry Schein (HSIC) | 0.0 | $278k | NEW | 4.2k | 66.37 |
|
| Supernus Pharmaceuticals (SUPN) | 0.0 | $255k | NEW | 5.3k | 47.79 |
|
| Humana (HUM) | 0.0 | $239k | 917.00 | 260.17 |
|
|
| Organon & Co Common Stock (OGN) | 0.0 | $175k | 16k | 10.68 |
|
|
| The Oncology Institute *w Exp 99/99/999 (TOIIW) | 0.0 | $150k | 1.3M | 0.12 |
|
|
| Tandem Diabetes Care Com New (TNDM) | 0.0 | $148k | NEW | 12k | 12.14 |
|
| Community Health Systems (CYH) | 0.0 | $105k | -41% | 33k | 3.21 |
|
| Quantum Si *w Exp 06/10/202 (QSIAW) | 0.0 | $90k | 333k | 0.27 |
|
|
| Nuvation Bio *w Exp 02/10/202 (NUVB.WS) | 0.0 | $34k | 167k | 0.20 |
|
|
| Butterfly Network *w Exp 02/12/202 (BFLY.WS) | 0.0 | $33k | 733k | 0.05 |
|
|
| Emergent BioSolutions (EBS) | 0.0 | $17k | 1.9k | 8.82 |
|
|
| Pmv Pharmaceuticals (PMVP) | 0.0 | $12k | 8.8k | 1.40 |
|
|
| Myriad Genetics (MYGN) | 0.0 | $3.7k | 505.00 | 7.23 |
|
|
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $3.0k | 167k | 0.02 |
|
Past Filings by Deerfield Management Company
SEC 13F filings are viewable for Deerfield Management Company going back to 2010
- Deerfield Management Company 2025 Q3 filed Nov. 14, 2025
- Deerfield Management Company 2025 Q2 filed Aug. 14, 2025
- Deerfield Management Company 2025 Q1 filed May 15, 2025
- Deerfield Management Company 2024 Q4 filed Feb. 14, 2025
- Deerfield Management Company 2024 Q3 filed Nov. 14, 2024
- Deerfield Management Company 2024 Q2 filed Aug. 14, 2024
- Deerfield Management Company 2024 Q1 filed May 15, 2024
- Deerfield Management Company 2023 Q4 filed Feb. 14, 2024
- Deerfield Management Company 2023 Q3 filed Nov. 14, 2023
- Deerfield Management Company 2023 Q2 filed Aug. 14, 2023
- Deerfield Management Company 2023 Q1 filed May 15, 2023
- Deerfield Management Company 2022 Q4 filed Feb. 14, 2023
- Deerfield Management Company 2022 Q3 filed Nov. 14, 2022
- Deerfield Management Company 2022 Q2 filed Aug. 15, 2022
- Deerfield Management Company 2022 Q1 filed May 16, 2022
- Deerfield Management Company 2021 Q4 filed Feb. 14, 2022